Bryce Zundel, et al vs. Amerilure, Inc., et al

Case Background

On May 10, 2022, Plaintiff ·Bryce Zundel ND Diane Zundel filed a Product Liability lawsuit in the Massachusetts State Superior Court of Middlesex County (Case number: 502022CA005480). Judge Jackie A. Cowin presided over the case.

Cause

The Zundels alleged that the defendants designed, manufactured, and sold asbestos-containing products, including talc-based products containing asbestos. Bryce Zundel was exposed to these products during medical treatments involving talc pleurodesis in 2014 and 2020 in Salt Lake City, Utah. Doctors administered the defendants' products intrapleurally around Bryce Zundel's left lung. In September 2021, doctors diagnosed Bryce Zundel with malignant pleural mesothelioma. During his diagnosis, physicians observed talc aggregations covering most of his lower lobe surface, posterior parietal pleura, diaphragmatic surface, and pericardial surfaces. The Zundels claimed that Bryce inhaled and ingested asbestos dust, fibers, and particles from the defendants' products during his medical treatments. As a result of these exposures, Bryce Zundel developed malignant pleural mesothelioma. He suffered serious personal injuries, endured pain, and required ongoing medical treatment. The Zundels alleged that the defendants failed to exercise reasonable care in designing, manufacturing, and selling their products. They also claimed that the defendants did not provide adequate warnings about the dangers of their products.

Injuries

The plaintiffs alleged that Bryce Zundel developed mesothelioma as a result of exposure to asbestos-containing products supplied by the defendants. Mesothelioma is a rare and aggressive cancer primarily caused by asbestos exposure. The complaint stated that Zundel underwent a talc pleurodesis treatment in 2014, before his mesothelioma diagnosis. This procedure used talc to adhere the lung to the chest wall, which the plaintiffs suggested might have contributed to Zundel's asbestos exposure. The lawsuit claimed that Zundel’s mesothelioma diagnosis followed shortly after his alleged exposure to the defendants' products. Boston Medical Products argued that due to the short